- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed B-Cell Non-Hodgkin Lymphoma in United States
Total 3918 results
-
University of UtahRecruitingAcute Lymphoblastic Leukemia | Diffuse Large B Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | CD19 PositiveUnited States
-
John ReneauActive, not recruitingRecurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma | Primary Cutaneous Anaplastic Large Cell Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia | Primary Myelofibrosis | Thrombocytopenia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Venous Thromboembolism | Myelodysplastic Syndrome | B-Cell Non-Hodgkin Lymphoma | Hematopoietic Cell Transplantation Recipient | Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
Massachusetts General HospitalGlaxoSmithKline; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical...CompletedFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic LymphomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Brigham and Women's HospitalCompletedB-cell Lymphoma | Indolent B-cell LymphomaUnited States
-
Kite, A Gilead CompanyRecruitingRelapsed and/or Refractory B-cell LymphomaUnited States, Netherlands, United Kingdom, Germany
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); California Institute for Regenerative Medicine...Active, not recruitingHIV Infection | Plasmablastic Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Adult Non-Hodgkin Lymphoma | Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Recurrent Burkitt Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Stage III Follicular... and other conditionsUnited States
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedT Cell Non-Hodgkin LymphomaUnited States
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Large B-cell LymphomaUnited States, Australia, Canada
-
Autolus LimitedCompletedDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | DLBCL | Relapsed Diffuse Large B-Cell LymphomaUnited States, United Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Recurrent Chronic Lymphocytic LeukemiaUnited States
-
Kite, A Gilead CompanyHumanigen, Inc.TerminatedRelapsed/Refractory Large B-cell LymphomaUnited States
-
University of ChicagoMerck Sharp & Dohme LLCRecruitingLymphoma | Lymphoma, B-Cell | B Cell Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell LymphomaUnited States
-
M.D. Anderson Cancer CenterWithdrawnB-cell Lymphoma | Large B-cell LymphomaUnited States
-
Brian HillThe Cleveland ClinicTerminatedLymphoma | B Cell LymphomaUnited States
-
Dipenkumar ModiGenmabRecruitingRelapsed Cancer | Refractory Cancer | Large Cell Lymphoma, DiffuseUnited States
-
Novartis PharmaceuticalsActive, not recruitingNon-Hodgkin LymphomaSpain, Taiwan, Australia, Belgium, Germany, Italy, Singapore, Austria, France, Switzerland, Hong Kong, United States, Netherlands, Norway, United Kingdom, Brazil, China, Japan
-
Medical College of WisconsinRecruitingFollicular Lymphoma | Multiple Myeloma | Burkitt Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Lymphoma, Small Lymphocytic | Diffuse Large B Cell Lymphoma | Central Nervous System Lymphoma | Lymphomas Non-Hodgkin's B-CellUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...TerminatedHodgkin Disease | Non-Hodgkins LymphomaUnited States
-
John ReneauRecruitingRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Adult T-Cell Leukemia/LymphomaUnited States
-
Jacob Soumerai, MDGlaxoSmithKlineRecruitingRelapsed Plasmablastic Lymphoma | Refractory Plasmablastic Lymphoma | Anaplastic Lymphoma Kinase Positive Large B-Cell LymphomaUnited States
-
Vanderbilt-Ingram Cancer CenterKite, A Gilead CompanyActive, not recruitingDiffuse Large B-cell Lymphoma | Large B-cell LymphomaUnited States
-
Pharmacyclics LLC.Celgene CorporationCompletedDiffuse Large B Cell Lymphoma Refractory | Diffuse Large B Cell Lymphoma RelapsedUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Active, not recruitingDiffuse Large B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma, Not Otherwise Specified | T-Cell/Histiocyte-Rich Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma... and other conditionsUnited States
-
AmgenCompletedLymphoma | Leukemia | Cancer | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Hematologic Malignancies | Diffuse Large Cell Lymphoma | Oncology | Tumors | T Cell Lymphoma | Oncology Patients | Hematology | Low Grade LymphomaUnited States
-
University of MiamiAstraZenecaTerminatedMarginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Small Lymphocytic LeukemiaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Incyte Corporation; Ipsen; BeiGeneRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Non-Hodgkin Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsUnited States
-
University of PennsylvaniaRecruitingAcute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non-hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Swedish Medical CenterAcerta Pharma BVRecruiting
-
Weill Medical College of Cornell UniversityBristol-Myers SquibbTerminatedDiffuse Large B-cell LymphomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterTerminatedDiffuse Large B Cell LymphomaUnited States
-
Massachusetts General HospitalNovartis; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterCompletedDiffuse Large B-cell LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Hoffmann-La RocheRecruitingLymphoma, Non-HodgkinUnited States, Belgium, Australia, Denmark, Italy, Spain, France, United Kingdom
-
Prelude TherapeuticsTerminatedFollicular Lymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Myeloproliferative Neoplasm | Small Lymphocytic Lymphoma | B-cell Non-Hodgkin LymphomaUnited States
-
University of ArizonaWithdrawnFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | Mediastinal Large B-cell Lymphoma | Grey Zone Lymphoma | High Grade B Cell LymphomaUnited States
-
Aegera TherapeuticsThe Leukemia and Lymphoma SocietyTerminatedLymphoma, B-Cell | Leukemia, Lymphocytic, Chronic, B-CellCanada, United States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; Genzyme, a Sanofi...CompletedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Peripheral T-cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Diffuse Large B-cell Lymphoma | Small Lymphocytic Lymphoma | Anaplastic Large-cell Lymphoma | Low Grade B-cell Lymphoma, Not Otherwise SpecifiedUnited States
-
David Bond, MDRecruitingRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent... and other conditionsUnited States
-
St. Jude Children's Research HospitalNovartis Pharmaceuticals; Spectrum Pharmaceuticals, IncTerminatedAcute Lymphoblastic Leukemia | Leukemia, B-Cell | Leukemia, T-Cell | Lymphoma, Non-Hodgkin'sUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationRecruitingDiffuse Large B Cell LymphomaUnited States
-
University of ChicagoMerck Sharp & Dohme LLCRecruitingLymphoma | Diffuse Large B Cell LymphomaUnited States
-
Fox Chase Cancer CenterActive, not recruitingDiffuse Large B Cell LymphomaUnited States
-
Weill Medical College of Cornell UniversityCompletedDiffuse Large B-cell LymphomaUnited States
-
Loyola UniversityGenta IncorporatedWithdrawn
-
Washington University School of MedicineAbbVieRecruiting
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic Leukemia (ALL) | Diffuse Large B-Cell Lymphoma (DLBCL)United States
-
Allogene TherapeuticsRecruitingRelapsed/Refractory Large B Cell LymphomaBelgium, United States, Austria